Aditxt, Inc. (ADTX:OTC) closed at $0.003 on October 2, 2026, down 6.06% on the day. The stock trades 100.0% below its 52-week high of $18,720.94 and 55.0% above its 52-week low of $0.002. Aditxt, Inc. is part of the Health Care sector.
Aditxt Inc is a life sciences company which focuses on prolong life and enhance life quality of transplanted patients. The firm develop products designed to induce tolerance to transplanted organs. The firm's immunosuppressive (anti-rejection) drugs has made possible life-saving organ transplantation procedures as these drugs prevent or delay organ rejection. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) which utilizes tolerogenic approach that utilizes the body's natural process of cell death, to deliver a modified antigen that signals the immune system to become tolerant to transplanted tissues.
Find more stocks like ADTX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.